These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23597957)

  • 21. [Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Kawano S
    Nihon Rinsho; 2007 May; 65 Suppl 5():91-7. PubMed ID: 17571371
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-adrenoceptor blockers in heart failure.
    Song J; White CM
    Conn Med; 1999 Dec; 63(12):719-22. PubMed ID: 10659472
    [No Abstract]   [Full Text] [Related]  

  • 23. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
    MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
    [No Abstract]   [Full Text] [Related]  

  • 24. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
    McMurray J; Cohen-Solal A; Dietz R; Eichhorn E; Erhardt L; Hobbs FD; Krum H; Maggioni A; McKelvie RS; Piña IL; Soler-Soler J; Swedberg K
    Eur J Heart Fail; 2005 Aug; 7(5):710-21. PubMed ID: 16087129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-blockers for heart failure.
    Med Lett Drugs Ther; 2000 Jun; 42(1081):54-5. PubMed ID: 10872031
    [No Abstract]   [Full Text] [Related]  

  • 26. [Beta blockers for therapy of chronic heart failure].
    Murakami T
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 28. Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
    Di Lenarda A; Sabbadini G; Sinagra G
    Cardiovasc Drugs Ther; 2004 Mar; 18(2):91-3. PubMed ID: 15293370
    [No Abstract]   [Full Text] [Related]  

  • 29. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic impact of switching from metoprolol to nebivolol for hypertension treatment: a retrospective database analysis.
    Chen S; Tourkodimitris S; Lukic T
    J Med Econ; 2014 Oct; 17(10):685-90. PubMed ID: 25007315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Does the use of metoprolol-succinate in patients with chronic heart failure lead to a higher efficacy in treatment without causing additional costs?].
    Sonntag F; Schöffski O; Hass B
    MMW Fortschr Med; 2005 Jun; 147(24):39. PubMed ID: 16001533
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of beta-blockers in heart failure].
    Inoko M; Nohara R
    Nihon Rinsho; 2003 May; 61(5):816-20. PubMed ID: 12755008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic benefits associated with beta blocker persistence in the treatment of hypertension: a retrospective database analysis.
    Chen S; Swallow E; Li N; Faust E; Kelley C; Xie J; Wu E
    Curr Med Res Opin; 2015 Apr; 31(4):615-22. PubMed ID: 25651483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reimbursement claims analysis of outcomes with carvedilol and metoprolol.
    Luzier AB; Antell LA; Chang LL; Xuan J; Roth DA
    Ann Pharmacother; 2002 Mar; 36(3):386-91. PubMed ID: 11895048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current research on carvedilol in heart failure.
    Bobadilla RV
    Crit Care Nurse; 2002 Aug; 22(4):14, 16. PubMed ID: 12166050
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
    Coats AJ
    Drugs Aging; 2006; 23(2):93-9. PubMed ID: 16536633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of beta-blockers on the adaptive immune system in chronic heart failure.
    Shaw SM; Coppinger T; Waywell C; Dunne L; Archer LD; Critchley WR; Yonan N; Fildes JE; Williams SG
    Cardiovasc Ther; 2009; 27(3):181-6. PubMed ID: 19689617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
    Stewart S; McMurray JJ; Hebborn A; Coats AJ; Packer M;
    Int J Cardiol; 2005 Apr; 100(1):143-9. PubMed ID: 15820297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of beta-blockers in the treatment of chronic heart heart failure].
    Czuriga I; Edes I
    Orv Hetil; 2001 Sep; 142(37):2005-12. PubMed ID: 11582731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective beta-blockers and mortality from heart failure.
    Seth S; Naik N; Mohan A
    Natl Med J India; 1999; 12(5):225-6. PubMed ID: 10613003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.